Skip to content

Gross margin at other companies

GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC
39.1%-2.9pp
Guardant Health logo
Guardant HealthGH
64.9%+3.6pp
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
99.3%-0.5pp
Labcorp Holdings logo
Labcorp HoldingsLH
28.8%+0.9pp
Agilent Technologies logo
Agilent TechnologiesA
52.7%-0.6pp
Danaher logo
DanaherDHR
58.9%-0.8pp

Other financials

Income statement

See full
Revenue$377.3M+1.2%
Gross profit$230.9M-2.9%
Operating income$81.3M-20.3%
Net income$118.4M+62.3%
EPS (diluted)$1.80+76.5%

Balance sheet

See full
Cash & equivalents$500.3M-46.8%
Total debt$627.9M+1.8%
Total equity$1.2B+4.1%
Total assets$2.3B+14.2%

Cash flow

See full
Operating cash flow$125.1M+16.3%
CapEx$3.2M-63.0%
Free cash flow$121.9M+23.3%

Valuation

See full
Market cap$6.76B-26.3%
Enterprise value$6.89B-20.5%
P/E24.2×-10.2×
P/S4.4×-1.6×

Profitability

See full
Operating margin18.8%-10.7pp
Net margin18%+0.7pp
FCF margin24.4%-6.4pp

Returns & leverage

See full
Return on equity23.5%-1.7pp
Debt / equity0.5×0.0×
Current ratio2.8×-2.9×

Where this comes from

Calculated from Lantheus Holdings’s reported figures.

Based on trailing twelve months.

The official record: Lantheus Holdings’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lantheus Holdings's gross margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Lantheus Holdings's gross margin?
Lantheus Holdings (LNTH) reported gross margin of 60.5% in Q1 2026.
How has Lantheus Holdings's gross margin changed year-over-year?
Lantheus Holdings's gross margin decreased by 5.6% year-over-year, from 64% to 60.5%.
What is the long-term trend for Lantheus Holdings's gross margin?
Over 5 years (2020 to 2025), Lantheus Holdings's gross margin has grown at a 8.4% compound annual growth rate (CAGR), from 40.9% to 61.1%.
What does gross margin mean?
Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.